The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Berger Mark Stanley since 2017.
The trader's CIK number is 1700283.
At the time of the last reporting, Berger Mark Stanley was the Chief Medical Officer of Actinium Pharmaceuticals, Inc.. (stock ticker symbol ATNM).
Also see all insider trading activities at Actinium Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | ATNM | 5,000 | $5,550 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-06-15 | ATNM | Buy | 5,000 | 1.11 | 5,550 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Berger Mark Stanley (Chief Medical Officer of Actinium Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.